[Effect of peroral blood glucose reducing therapy on insulin receptor interactions in patients with type II diabetes mellitus].
D000328:Adult; D000368:Aged; D001645:Biguanides / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D007328:Insulin / Q000032:analysis*; D008875:Middle Aged; D009000:Monocytes / Q000032:analysis; D011869:Radioligand Assay; D011972:Receptor, Insulin / Q000032:analysis*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
D001645:Biguanides; D007328:Insulin; D013453:Sulfonylurea Compounds; D011972:Receptor, Insulin
Vliianie peroral'noĭ gipoglikemiziruiushcheĭ terapii na protsessy insulinoretseptornogo vzaimodeĭstviia u bol'nykh sakharnym diabetom II tipa.